Developmental screening of full-term infants at 16 to 18 months of age after in-utero exposure to maternal SARS-CoV-2 infection

Abstract

Abstract Full-term infants born to mothers with SARS-CoV-2 infection may be at increased risk for neurodevelopmental delays at 16 to 18 months of life. Infants born to the mothers with mild symptoms had no differences in outcomes during developmental screening than those born to asymptomatic mothers with SARS-CoV-2.